Homodimerization of the death-associated protein kinase catalytic domain: development of a new small molecule

Michael Zimmermann1, Cédric Atmanene, Qingyan Xu

  • 1Laboratoire d'Innovation Thérapeutique, Unité Mixte de Recherche 7200, Centre National de la Recherche Scientifique, Université de Strasbourg, Faculté de Pharmacie, Illkirch, France.

Plos One
|December 15, 2010
PubMed
Abstract

Insights

Death-Associated Protein Kinase (DAPK) homodimerization involves its basic loop structure. This study reveals a monomer-dimer equilibrium critical for DAPK function and potential therapeutic targeting.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • Death-Associated Protein Kinase (DAPK) is a Ca2+/calmodulin-regulated serine/threonine kinase.
  • DAPK plays a role in induced cell death.
  • DAPK is a therapeutic target for brain injuries and neurodegenerative diseases.

Purpose of the Study:

  • To investigate the homodimerization of the DAPK catalytic domain.
  • To elucidate the role of the basic loop structure in DAPK oligomerization.
  • To develop methods for monitoring DAPK oligomerization state.

Main Methods:

  • Nanoelectrospray ionization mass spectrometry (NSI-MS) was used to study DAPK catalytic domain and a basic loop mutant.
  • Chemical biology approaches were employed to identify a fluorescent probe.
  • The probe was used to monitor the protein's oligomerization state in solution.

Main Results:

  • Homodimerization of the DAPK catalytic domain was observed.
  • The basic loop structure was identified as crucial for DAPK homodimerization.
  • A monomer-dimer equilibrium was elucidated, involving the basic loop.

Conclusions:

  • A monomer-dimer equilibrium of DAPK was characterized.
  • The basic loop is essential for DAPK homodimerization.
  • An allosteric conformational change, independent of the basic loop, was detected using a fluorescent probe.

Related Concept Videos